Form 4 Filing for Ginkgo Bioworks Holdings, Inc.

This filing details stock transactions by Jason R. Kelly, CEO & Founder of Ginkgo Bioworks Holdings, Inc. (DNA). On April 7-8, 2026, Kelly acquired 425,898 shares of Class A Common Stock through the vesting of Performance-Based Restricted Stock Units (PSUs). These PSUs, granted on June 19, 2025, vested at 67% of the target performance. Concurrently, on April 8-9, 2026, Kelly sold 206,782 shares of Class A Common Stock to cover tax withholding obligations related to the PSU vesting. These sales were executed under the company's equity incentive plan, allowing for "sell to cover" transactions to satisfy tax liabilities. Following these transactions, Kelly holds 316,483 shares of Class A Common Stock directly.